A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker
一项针对晚期肝脏实体瘤患者的双硫仑和葡萄糖酸铜的1期剂量递增研究，以S-谷胱甘肽化作为生物标志物。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-08242-4
Kelley, Kristen C; Grossman, Kenneth F; Brittain-Blankenship, Mary; Thorne, Kelli M; Akerley, Wallace L; Terrazas, Moises C; Kosak, Ken M; Boucher, Kenneth M; Buys, Saundra S; McGregor, Kimberly A; Werner, Theresa L; Agarwal, Neeraj; Weis, John R; Sharma, Sunil; Ward, John H; Kennedy, Thomas P; Sborov, Douglas W; Shami, Paul J
